Unique ID issued by UMIN | UMIN000028616 |
---|---|
Receipt number | R000032751 |
Scientific Title | The multicenter study to examine angiogenesis-related factors in advanced colorectal cancer |
Date of disclosure of the study information | 2017/09/21 |
Last modified on | 2023/08/16 20:33:34 |
The multicenter study to examine angiogenesis-related factors in advanced colorectal cancer
GI-SCREEN CRC-Ukit
The multicenter study to examine angiogenesis-related factors in advanced colorectal cancer
GI-SCREEN CRC-Ukit
Japan |
Colorectal cancer
Gastroenterology |
Malignancy
NO
Relationship between angiogenesis-related factors and therapeutic effects in advanced colorectal cancer
Others
Association between pre-treatment angiogenesis-related factors and clinicopathological features
Fluctuant of factors angiogenesis-related factors pre- and post chemotherapy
Relationship between angiogenesis-related factors and therapeutic effects in advanced colorectal cancer
Association between pre-treatment angiogenesis-related factors and clinicopathological features
Fluctuant of factors angiogenesis-related factors pre- and post chemotherapy
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1)Patients with pathologically or histologically confirmed colorectal cancer
2)Patient with indication of chemotherapy with unresectable metastasis or recurrent disease
3)Confirmed RAS mutational status
4)Meet the following (1) or (2)
(1)Patients who have not administerd chemotherapy for metastatic disease
(2)Patients immediately after completion of chemotherapy plus bevacizumab or chemothrapy plus anti-EGFR antibody for the first line treatment for metastatic disease
5)Patient who is planned to receive following (1) to (5) after registration
(1)chemotherapy plus bevacizumab (first line)
(2)chemotherapy plus anti-EGFR antibody (first line)
(3)FOLFIRI plus ramucirumab (second line)
(4)FOLFIRI plus aflibercept (second line)
(5)chemotherapy plus bevacizumab (second line)
6)Age 20 years or above
7)Written informed consent was obtained
1)Judged by the investigator to be inappropriate for study participation for any reason
500
1st name | Takayuki |
Middle name | |
Last name | Yoshino |
National Cancer Center Hospital East
Department of Gastrointestinal Oncology
277-8577
6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan
04-7133-1111
tyoshino@east.ncc.go.jp
1st name | Satoshi |
Middle name | |
Last name | Yuki |
Hokkaido University Hospital
Department of Gastroenterology and Hepatology
060-8648
Kita-15, Nishi-7, Kita-ku, Sapporo, Hokkaido, 060-8648, Japan
011-706-5657
satoshi-yuuki175@joy.ocn.ne.jp
National Cancer Center Hospital East
Japan Agency for Medical Research and Develop,ent
Non profit foundation
G&G Science Co., Ltd
Clinical Research and Medical Innovation Center, Hokkaido University Hospital
Kita-15, Nishi-7, Kita-ku, Sapporo, Hokkaido, 060-8648, Japan
011-706-7413
REG_DC@pop.med.hokudai.ac.jp
NO
2017 | Year | 09 | Month | 21 | Day |
Partially published
498
Delay expected |
Paper not accepted
Completed
2017 | Year | 08 | Month | 09 | Day |
2017 | Year | 12 | Month | 12 | Day |
2017 | Year | 10 | Month | 01 | Day |
2021 | Year | 09 | Month | 30 | Day |
Study Design: Observational study
Target population:the patients who visit the research implementation facility until September 30 2020 from research permit date and meet the selection criteria
If the patient is participating in GI-SCREEN 2013-01-CRC (UMIN000016343)/GI-SCREEN CRC-MSI(UMIN000020437), we investigate the association between results of both analysis data.
2017 | Year | 08 | Month | 09 | Day |
2023 | Year | 08 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032751
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |